IMMIX BIOPHARMA, INC.

Lobbying client · California · filed 2026 to 2026

A clinical-stage biopharmaceutical company.

$155,000 Reported spend

3 Filings counted

1 Firms hired

0 Bills named

Spend is reported income plus in-house expenses across 3 filings. Everything on this page is grouped by the client's LDA id (71337), not by name.

Firms hired 1

CONTINENTAL STRATEGY, LLC $155,000 3 filings

Reported by year 1 year

2026 $155,000 3 filings

Issues lobbied 1

Medical/Disease Research/Clinical Labs 2

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

Agencies and chambers lobbied 4

Agriculture, Dept of (USDA) 1
Health Resources & Services Administration (HRSA) 1
HOUSE OF REPRESENTATIVES 1
SENATE 1

Recent filings 3 total

Q2

CONTINENTAL STRATEGY, LLC

2nd Quarter (Apr 1 - June 30) 2026 · House · Senate · $105,000 income · posted Jul 19, 2026

View → Q1Y

CONTINENTAL STRATEGY, LLC

1st Quarter (Jan 1 - Mar 31) 2026 · $50,000 income · posted Apr 20, 2026

View → RR

CONTINENTAL STRATEGY, LLC

1st Quarter (Jan 1 - Mar 31) 2026 · posted Feb 19, 2026

View →

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.